Cefadroxil

DRUG7 trials

Sponsors

Karlstad University, National University Hospital, Singapore, Genuine Research Center, Egypt, AbbVie, University of Colorado, Denver

Conditions

Autoimmune DiseasesBacterial InfectionsChronic Kidney DiseasesDiabetesHealthyInfections Joint ProstheticInflammatory DiseaseJoint Infection

Phase 1

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

CompletedNCT02479867

Genuine Research Center, EgyptHealthy

Start: 2014-03-31End: 2014-04-30Updated: 2015-06-24

Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections

CompletedNCT03802552

University of Colorado, DenverOsteomyelitis, Pyomyositis, Septic Arthritis

Start: 2019-05-01End: 2021-04-30Updated: 2021-06-02

Phase 2

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

CompletedNCT02381470

National University Hospital, SingaporePulmonary Tuberculosis

Start: 2019-02-11End: 2019-10-02Updated: 2020-03-23

Phase 3

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

CompletedNCT02814916

AbbVieBacterial Infections, Methicillin-Resistant Staphylococcus Aureus, Staphylococcal Skin Infections

Start: 2017-03-30End: 2024-01-01Updated: 2024-09-19

Or v IV Antibiotics for Infection

Rothman Institute OrthopaedicsJoint Infection

Start: 2021-01-25End: 2023-01-25Target: 308Updated: 2021-01-26

Phase 4

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Enrolling by invitationNCT04297592

Mayo ClinicAutoimmune Diseases, Chronic Kidney Diseases, Diabetes +6

Start: 2020-06-11End: 2026-06-30Target: 4618Updated: 2025-07-03

Unknown Phase

Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding

CompletedNCT00405158

Karlstad UniversityMastitis

Start: 2002-01-31End: 2004-03-31Target: 210Updated: 2006-12-04

Related Papers

The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections

The Pediatric Infectious Disease Journal2022-12-0719 citations